1 |
FLT4
| [8] MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D03218
D03218
|
Axitinib
| [1] 34 34 |
2 |
FLT4
| [8] MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D08524
D08524
|
Sorafenib
| [2] 34 34, 86 |
3 |
FLT4
| [8] MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D08552
D08552
|
Sunitinib
| [2] 28 28, 34 |
4 |
FLT4
| [8] MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D08881
D08881
|
Cediranib
| [1] 34 34 |
5 |
FLT4
| [8] MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D10481
D10481
|
Nintedanib
| [5] 51 51, 85, 89, 227, 228 |
6 |
FLT4
| [8] MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | D11772
D11772
|
Tesevatinib
| [1] 67 67 |